Royal London Asset Management Ltd. Has $3.28 Million Stake in DaVita Inc. (NYSE:DVA)

Royal London Asset Management Ltd. lifted its stake in DaVita Inc. (NYSE:DVA) by 6.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 21,926 shares of the company’s stock after purchasing an additional 1,242 shares during the quarter. Royal London Asset Management Ltd.’s holdings in DaVita were worth $3,279,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of DVA. Franklin Resources Inc. increased its stake in shares of DaVita by 134.6% in the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after buying an additional 31,502 shares during the period. FMR LLC boosted its holdings in DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after acquiring an additional 154,061 shares during the last quarter. Atom Investors LP bought a new stake in DaVita during the 3rd quarter worth about $4,094,000. Assenagon Asset Management S.A. lifted its position in DaVita by 201.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock valued at $11,159,000 after purchasing an additional 49,885 shares during the period. Finally, Neo Ivy Capital Management bought a new position in shares of DaVita in the 3rd quarter valued at about $726,000. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

Shares of DaVita stock opened at $150.56 on Tuesday. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The company has a market capitalization of $12.04 billion, a PE ratio of 14.02, a PEG ratio of 1.07 and a beta of 0.99. The stock’s fifty day simple moving average is $158.40 and its 200 day simple moving average is $157.57.

DaVita (NYSE:DVA) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently weighed in on DVA shares. Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. StockNews.com downgraded DaVita from a “buy” rating to a “hold” rating in a research note on Friday. Barclays lifted their price objective on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on DaVita in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, DaVita presently has a consensus rating of “Hold” and a consensus price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.